Article
Myelin-reactive B cells exacerbate the severity of CD4+ T cell-driven CNS autoimmunity in…
medRxiv · 2023 · Fazazi, M. R.; Doss, P. M. I. A.; Pereira, R.; Fudge, N.; Regmi, A.; Joly-Beauparlant, C.; Akbar, I.; Yeola, A. P.; Mailhot, B.; Baillargeon, J.; Grenier, P.; Bertrand, N.; Lacroix, S.; Droit, A.; Moore, C. S.; Rojas, O. L.; Rangachari, M.
Key facts
| Title | Myelin-reactive B cells exacerbate the severity of CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner. |
|---|---|
| First author | Fazazi, M. R.; Doss, P. M. I. A.; Pereira, R.; Fudge, N.; Regmi, A.; Joly-Beauparlant, C.; Akbar, I.; Yeola, A. P.; Mailhot, B.; Baillargeon, J.; Grenier, P.; Bertrand, N.; Lacroix, S.; Droit, A.; Moore, C. S.; Rojas, O. L.; Rangachari, M. |
| Journal | medRxiv |
| Published | Sep 6, 2023 |
| DOI | 10.1101/721696 |
| Devices mentioned | K010696, K073487, K073490, K822496 |
| Product codes mentioned | CFN, JIS, JIT, JJH |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1